1. Home
  2. ATLO vs INBX Comparison

ATLO vs INBX Comparison

Compare ATLO & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ames National Corporation

ATLO

Ames National Corporation

N/A

Current Price

$22.98

Market Cap

205.2M

Sector

Finance

ML Signal

N/A

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$80.11

Market Cap

430.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLO
INBX
Founded
1903
2010
Country
United States
United States
Employees
231
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.2M
430.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ATLO
INBX
Price
$22.98
$80.11
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
27.2K
242.1K
Earning Date
01-23-2026
11-14-2025
Dividend Yield
3.47%
N/A
EPS Growth
82.57
N/A
EPS
1.80
N/A
Revenue
$60,568,000.00
$1,400,000.00
Revenue This Year
N/A
$563.00
Revenue Next Year
N/A
N/A
P/E Ratio
$12.85
N/A
Revenue Growth
18.60
N/A
52 Week Low
$16.04
$10.81
52 Week High
$24.36
$94.57

Technical Indicators

Market Signals
Indicator
ATLO
INBX
Relative Strength Index (RSI) 60.80 49.85
Support Level $22.62 $76.22
Resistance Level $24.12 $94.57
Average True Range (ATR) 0.53 7.21
MACD -0.09 -1.31
Stochastic Oscillator 52.20 28.54

Price Performance

Historical Comparison
ATLO
INBX

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: